NO120145B - - Google Patents
Download PDFInfo
- Publication number
- NO120145B NO120145B NO168663A NO16866367A NO120145B NO 120145 B NO120145 B NO 120145B NO 168663 A NO168663 A NO 168663A NO 16866367 A NO16866367 A NO 16866367A NO 120145 B NO120145 B NO 120145B
- Authority
- NO
- Norway
- Prior art keywords
- hydrogen
- ammonia
- formula
- mixture
- group
- Prior art date
Links
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 claims description 40
- 229910021529 ammonia Inorganic materials 0.000 claims description 17
- 150000003839 salts Chemical class 0.000 claims description 17
- 229910052739 hydrogen Inorganic materials 0.000 claims description 15
- 239000001257 hydrogen Substances 0.000 claims description 15
- 239000002253 acid Substances 0.000 claims description 10
- -1 alkali metal amide Chemical class 0.000 claims description 10
- 150000003863 ammonium salts Chemical class 0.000 claims description 10
- 229910052727 yttrium Inorganic materials 0.000 claims description 10
- 150000002431 hydrogen Chemical class 0.000 claims description 8
- 150000001409 amidines Chemical class 0.000 claims description 7
- 125000003545 alkoxy group Chemical group 0.000 claims description 6
- 238000000034 method Methods 0.000 claims description 6
- 125000004432 carbon atom Chemical group C* 0.000 claims description 5
- 239000003054 catalyst Substances 0.000 claims description 5
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 4
- 125000004414 alkyl thio group Chemical group 0.000 claims description 4
- 238000004519 manufacturing process Methods 0.000 claims description 4
- 125000001931 aliphatic group Chemical group 0.000 claims description 3
- 229910052783 alkali metal Inorganic materials 0.000 claims description 3
- 125000003118 aryl group Chemical group 0.000 claims description 3
- 229910052736 halogen Inorganic materials 0.000 claims description 2
- 150000002367 halogens Chemical class 0.000 claims description 2
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims description 2
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 claims 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 35
- 239000000203 mixture Substances 0.000 description 27
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 22
- 150000001875 compounds Chemical class 0.000 description 22
- 239000000243 solution Substances 0.000 description 17
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 15
- 238000006243 chemical reaction Methods 0.000 description 14
- 238000002844 melting Methods 0.000 description 14
- 230000008018 melting Effects 0.000 description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 12
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 8
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 6
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 6
- 235000011114 ammonium hydroxide Nutrition 0.000 description 6
- 239000000463 material Substances 0.000 description 6
- 229920006395 saturated elastomer Polymers 0.000 description 6
- 239000000706 filtrate Substances 0.000 description 5
- 150000002825 nitriles Chemical class 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 238000001953 recrystallisation Methods 0.000 description 5
- 239000002904 solvent Substances 0.000 description 5
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 5
- OEWPDZVHFDWAIH-UHFFFAOYSA-N 2-(3-chlorophenoxy)propanenitrile Chemical compound N#CC(C)OC1=CC=CC(Cl)=C1 OEWPDZVHFDWAIH-UHFFFAOYSA-N 0.000 description 4
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 4
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 4
- 150000002463 imidates Chemical class 0.000 description 4
- 238000010992 reflux Methods 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- UMGDCJDMYOKAJW-UHFFFAOYSA-N thiourea Chemical compound NC(N)=S UMGDCJDMYOKAJW-UHFFFAOYSA-N 0.000 description 4
- 238000011282 treatment Methods 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 239000002585 base Substances 0.000 description 3
- 238000009835 boiling Methods 0.000 description 3
- 239000008187 granular material Substances 0.000 description 3
- 150000003840 hydrochlorides Chemical class 0.000 description 3
- 229910000039 hydrogen halide Inorganic materials 0.000 description 3
- 239000012433 hydrogen halide Substances 0.000 description 3
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 3
- BDHFUVZGWQCTTF-UHFFFAOYSA-N sulfonic acid Chemical compound OS(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-N 0.000 description 3
- ABYGZZIGDUNFGL-UHFFFAOYSA-N 2-(3-chlorophenoxy)propanethioamide Chemical compound NC(=S)C(C)OC1=CC=CC(Cl)=C1 ABYGZZIGDUNFGL-UHFFFAOYSA-N 0.000 description 2
- UWMNNLOPVAKMID-UHFFFAOYSA-N 2-(3-chlorophenoxy)propanimidamide 4-methylbenzenesulfonic acid Chemical compound C1(=CC=C(C=C1)S(=O)(=O)O)C.ClC=1C=C(OC(C(=N)N)C)C=CC1 UWMNNLOPVAKMID-UHFFFAOYSA-N 0.000 description 2
- LSGPRLNRMANBIG-UHFFFAOYSA-N 2-(4-chlorophenoxy)ethanimidamide Chemical compound NC(=N)COC1=CC=C(Cl)C=C1 LSGPRLNRMANBIG-UHFFFAOYSA-N 0.000 description 2
- GGJZNRRFDCKJCD-UHFFFAOYSA-N 2-phenoxyethanimidamide Chemical class NC(=N)COC1=CC=CC=C1 GGJZNRRFDCKJCD-UHFFFAOYSA-N 0.000 description 2
- PRBKNBDNRRUMRE-UHFFFAOYSA-N 2-phenoxypropanimidamide Chemical class NC(=N)C(C)OC1=CC=CC=C1 PRBKNBDNRRUMRE-UHFFFAOYSA-N 0.000 description 2
- HORNXRXVQWOLPJ-UHFFFAOYSA-N 3-chlorophenol Chemical compound OC1=CC=CC(Cl)=C1 HORNXRXVQWOLPJ-UHFFFAOYSA-N 0.000 description 2
- RJWBTWIBUIGANW-UHFFFAOYSA-N 4-chlorobenzenesulfonic acid Chemical compound OS(=O)(=O)C1=CC=C(Cl)C=C1 RJWBTWIBUIGANW-UHFFFAOYSA-N 0.000 description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonium chloride Substances [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- RWTYVHSDHHDECI-UHFFFAOYSA-N Cl.ClC=1C=C(OC(C(=N)N)C)C=CC1 Chemical compound Cl.ClC=1C=C(OC(C(=N)N)C)C=CC1 RWTYVHSDHHDECI-UHFFFAOYSA-N 0.000 description 2
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 2
- WTDHULULXKLSOZ-UHFFFAOYSA-N Hydroxylamine hydrochloride Chemical compound Cl.ON WTDHULULXKLSOZ-UHFFFAOYSA-N 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- 125000000066 S-methyl group Chemical group [H]C([H])([H])S* 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Natural products NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- SOIFLUNRINLCBN-UHFFFAOYSA-N ammonium thiocyanate Chemical compound [NH4+].[S-]C#N SOIFLUNRINLCBN-UHFFFAOYSA-N 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 238000002425 crystallisation Methods 0.000 description 2
- 230000008025 crystallization Effects 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- AEOCXXJPGCBFJA-UHFFFAOYSA-N ethionamide Chemical compound CCC1=CC(C(N)=S)=CC=N1 AEOCXXJPGCBFJA-UHFFFAOYSA-N 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 2
- 238000002329 infrared spectrum Methods 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 230000002085 persistent effect Effects 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- WPZSAUFQHYFIPG-UHFFFAOYSA-N propanethioamide Chemical compound CCC(N)=S WPZSAUFQHYFIPG-UHFFFAOYSA-N 0.000 description 2
- MHOVAHRLVXNVSD-UHFFFAOYSA-N rhodium atom Chemical compound [Rh] MHOVAHRLVXNVSD-UHFFFAOYSA-N 0.000 description 2
- KVCGISUBCHHTDD-UHFFFAOYSA-M sodium;4-methylbenzenesulfonate Chemical compound [Na+].CC1=CC=C(S([O-])(=O)=O)C=C1 KVCGISUBCHHTDD-UHFFFAOYSA-M 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 238000004809 thin layer chromatography Methods 0.000 description 2
- SFLSHLFXELFNJZ-QMMMGPOBSA-N (-)-norepinephrine Chemical compound NC[C@H](O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-QMMMGPOBSA-N 0.000 description 1
- KSVNOFHIFZIZHO-UHFFFAOYSA-N 2-(3-bromophenoxy)propanimidamide Chemical compound NC(=N)C(C)OC1=CC=CC(Br)=C1 KSVNOFHIFZIZHO-UHFFFAOYSA-N 0.000 description 1
- OJEXDCJEEJAVIA-UHFFFAOYSA-N 2-(3-chlorophenoxy)propanimidamide Chemical compound NC(=N)C(C)OC1=CC=CC(Cl)=C1 OJEXDCJEEJAVIA-UHFFFAOYSA-N 0.000 description 1
- ZOEMFBXKOXSLIN-UHFFFAOYSA-N 2-(3-chlorophenoxy)propanimidamide hydroiodide Chemical compound I.ClC=1C=C(OC(C(=N)N)C)C=CC1 ZOEMFBXKOXSLIN-UHFFFAOYSA-N 0.000 description 1
- NFKBMFROTLXSLD-UHFFFAOYSA-N 2-(3-fluorophenoxy)propanimidamide Chemical compound NC(=N)C(C)OC1=CC=CC(F)=C1 NFKBMFROTLXSLD-UHFFFAOYSA-N 0.000 description 1
- BMPGGDBVJBYPRA-UHFFFAOYSA-N 2-(3-methoxyphenoxy)propanenitrile Chemical compound COC1=CC=CC(OC(C)C#N)=C1 BMPGGDBVJBYPRA-UHFFFAOYSA-N 0.000 description 1
- UYCNOMSEXPUQTB-UHFFFAOYSA-N 2-(4-chlorophenoxy)propanimidamide Chemical compound NC(=N)C(C)OC1=CC=C(Cl)C=C1 UYCNOMSEXPUQTB-UHFFFAOYSA-N 0.000 description 1
- ZAVSPGJDAHKCPE-UHFFFAOYSA-N 2-(4-methoxyphenoxy)ethanimidamide Chemical compound COC1=CC=C(OCC(N)=N)C=C1 ZAVSPGJDAHKCPE-UHFFFAOYSA-N 0.000 description 1
- ZFFBIQMNKOJDJE-UHFFFAOYSA-N 2-bromo-1,2-diphenylethanone Chemical compound C=1C=CC=CC=1C(Br)C(=O)C1=CC=CC=C1 ZFFBIQMNKOJDJE-UHFFFAOYSA-N 0.000 description 1
- JNAYPRPPXRWGQO-UHFFFAOYSA-N 2-chloropropanenitrile Chemical compound CC(Cl)C#N JNAYPRPPXRWGQO-UHFFFAOYSA-N 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- BEQAXQFDRFDRFN-UHFFFAOYSA-N C1(=CC=CC=C1)S(=O)(=O)O.ClC=1C=C(OC(C(=N)N)C)C=CC1 Chemical compound C1(=CC=CC=C1)S(=O)(=O)O.ClC=1C=C(OC(C(=N)N)C)C=CC1 BEQAXQFDRFDRFN-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- SSJVMRKIOZHZDX-UHFFFAOYSA-N Cl.COC=1C=C(OC(C(N)=NO)C)C=CC1 Chemical compound Cl.COC=1C=C(OC(C(N)=NO)C)C=CC1 SSJVMRKIOZHZDX-UHFFFAOYSA-N 0.000 description 1
- XFXPMWWXUTWYJX-UHFFFAOYSA-N Cyanide Chemical compound N#[C-] XFXPMWWXUTWYJX-UHFFFAOYSA-N 0.000 description 1
- RWSOTUBLDIXVET-UHFFFAOYSA-N Dihydrogen sulfide Chemical compound S RWSOTUBLDIXVET-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 1
- 239000007868 Raney catalyst Substances 0.000 description 1
- NPXOKRUENSOPAO-UHFFFAOYSA-N Raney nickel Chemical compound [Al].[Ni] NPXOKRUENSOPAO-UHFFFAOYSA-N 0.000 description 1
- 229910000564 Raney nickel Inorganic materials 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- ZMZDMBWJUHKJPS-UHFFFAOYSA-M Thiocyanate anion Chemical compound [S-]C#N ZMZDMBWJUHKJPS-UHFFFAOYSA-M 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- SWLVFNYSXGMGBS-UHFFFAOYSA-N ammonium bromide Chemical compound [NH4+].[Br-] SWLVFNYSXGMGBS-UHFFFAOYSA-N 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 235000011130 ammonium sulphate Nutrition 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- SRSXLGNVWSONIS-UHFFFAOYSA-N benzenesulfonic acid Chemical compound OS(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-N 0.000 description 1
- 229940092714 benzenesulfonic acid Drugs 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 150000001722 carbon compounds Chemical class 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 206010061592 cardiac fibrillation Diseases 0.000 description 1
- 150000003943 catecholamines Chemical class 0.000 description 1
- SFZULDYEOVSIKM-UHFFFAOYSA-N chembl321317 Chemical compound C1=CC(C(=N)NO)=CC=C1C1=CC=C(C=2C=CC(=CC=2)C(=N)NO)O1 SFZULDYEOVSIKM-UHFFFAOYSA-N 0.000 description 1
- 150000001860 citric acid derivatives Chemical class 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000003001 depressive effect Effects 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 239000012259 ether extract Substances 0.000 description 1
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 230000002600 fibrillogenic effect Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000007903 gelatin capsule Substances 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 230000010247 heart contraction Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 229910000042 hydrogen bromide Inorganic materials 0.000 description 1
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical class I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 1
- 229910000037 hydrogen sulfide Inorganic materials 0.000 description 1
- ZMZDMBWJUHKJPS-UHFFFAOYSA-N hydrogen thiocyanate Natural products SC#N ZMZDMBWJUHKJPS-UHFFFAOYSA-N 0.000 description 1
- 238000005984 hydrogenation reaction Methods 0.000 description 1
- 150000002464 imidothioesters Chemical class 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000013067 intermediate product Substances 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 150000003893 lactate salts Chemical class 0.000 description 1
- 230000001050 lubricating effect Effects 0.000 description 1
- 150000002688 maleic acid derivatives Chemical class 0.000 description 1
- 229960002523 mercuric chloride Drugs 0.000 description 1
- LWJROJCJINYWOX-UHFFFAOYSA-L mercury dichloride Chemical compound Cl[Hg]Cl LWJROJCJINYWOX-UHFFFAOYSA-L 0.000 description 1
- 238000005649 metathesis reaction Methods 0.000 description 1
- VUQUOGPMUUJORT-UHFFFAOYSA-N methyl 4-methylbenzenesulfonate Chemical compound COS(=O)(=O)C1=CC=C(C)C=C1 VUQUOGPMUUJORT-UHFFFAOYSA-N 0.000 description 1
- 125000002816 methylsulfanyl group Chemical group [H]C([H])([H])S[*] 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000012299 nitrogen atmosphere Substances 0.000 description 1
- 229960002748 norepinephrine Drugs 0.000 description 1
- SFLSHLFXELFNJZ-UHFFFAOYSA-N norepinephrine Natural products NCC(O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-UHFFFAOYSA-N 0.000 description 1
- 150000003891 oxalate salts Chemical class 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000002798 polar solvent Substances 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- JCELWBLXFXQPMF-UHFFFAOYSA-N propanethioamide;hydroiodide Chemical compound I.CCC(S)=N JCELWBLXFXQPMF-UHFFFAOYSA-N 0.000 description 1
- 238000011321 prophylaxis Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 229910052703 rhodium Inorganic materials 0.000 description 1
- 239000010948 rhodium Substances 0.000 description 1
- XMVJITFPVVRMHC-UHFFFAOYSA-N roxarsone Chemical group OC1=CC=C([As](O)(O)=O)C=C1[N+]([O-])=O XMVJITFPVVRMHC-UHFFFAOYSA-N 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229940077386 sodium benzenesulfonate Drugs 0.000 description 1
- MZSDGDXXBZSFTG-UHFFFAOYSA-M sodium;benzenesulfonate Chemical compound [Na+].[O-]S(=O)(=O)C1=CC=CC=C1 MZSDGDXXBZSFTG-UHFFFAOYSA-M 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 150000003890 succinate salts Chemical class 0.000 description 1
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 1
- 230000002889 sympathetic effect Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 150000003892 tartrate salts Chemical class 0.000 description 1
- 238000011287 therapeutic dose Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000005550 wet granulation Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Heart & Thoracic Surgery (AREA)
- Engineering & Computer Science (AREA)
- Cardiology (AREA)
- Epidemiology (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB27627/66A GB1194183A (en) | 1966-06-21 | 1966-06-21 | Biologically Active Propionamidines and their preparation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO120145B true NO120145B (xx) | 1970-09-07 |
Family
ID=10262684
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO168663A NO120145B (xx) | 1966-06-21 | 1967-06-20 |
Country Status (18)
| Country | Link |
|---|---|
| JP (2) | JPS4927859B1 (xx) |
| AT (1) | AT291220B (xx) |
| BE (1) | BE700096A (xx) |
| CA (1) | CA939385A (xx) |
| CH (1) | CH509273A (xx) |
| CS (1) | CS177802B2 (xx) |
| DE (1) | DE1643216A1 (xx) |
| DK (1) | DK126376B (xx) |
| ES (1) | ES342072A1 (xx) |
| FI (1) | FI48461C (xx) |
| FR (2) | FR1572961A (xx) |
| GB (1) | GB1194183A (xx) |
| GR (1) | GR34158B (xx) |
| IL (1) | IL28120A (xx) |
| LU (1) | LU53925A1 (xx) |
| NL (1) | NL6708561A (xx) |
| NO (1) | NO120145B (xx) |
| SE (1) | SE339468B (xx) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS53144676U (xx) * | 1977-04-21 | 1978-11-15 |
-
1966
- 1966-06-21 GB GB27627/66A patent/GB1194183A/en not_active Expired
-
1967
- 1967-06-06 GR GR670134158A patent/GR34158B/el unknown
- 1967-06-07 CA CA992,470A patent/CA939385A/en not_active Expired
- 1967-06-09 IL IL28120A patent/IL28120A/xx unknown
- 1967-06-15 CH CH849767A patent/CH509273A/de not_active IP Right Cessation
- 1967-06-16 BE BE700096D patent/BE700096A/xx unknown
- 1967-06-16 AT AT560067A patent/AT291220B/de not_active IP Right Cessation
- 1967-06-19 DK DK316667AA patent/DK126376B/da unknown
- 1967-06-19 SE SE08607/67A patent/SE339468B/xx unknown
- 1967-06-20 FI FI671731A patent/FI48461C/fi active
- 1967-06-20 NL NL6708561A patent/NL6708561A/xx unknown
- 1967-06-20 DE DE19671643216 patent/DE1643216A1/de active Pending
- 1967-06-20 NO NO168663A patent/NO120145B/no unknown
- 1967-06-20 ES ES342072A patent/ES342072A1/es not_active Expired
- 1967-06-20 LU LU53925D patent/LU53925A1/xx unknown
- 1967-06-21 CS CS4552A patent/CS177802B2/cs unknown
- 1967-06-21 JP JP42039388A patent/JPS4927859B1/ja active Pending
- 1967-06-21 FR FR1572961D patent/FR1572961A/fr not_active Expired
- 1967-09-19 FR FR121436A patent/FR6910M/fr not_active Expired
-
1970
- 1970-06-01 JP JP45046452A patent/JPS4933941B1/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| GR34158B (el) | 1968-03-30 |
| FI48461C (fi) | 1974-10-10 |
| LU53925A1 (xx) | 1968-03-11 |
| IL28120A (en) | 1971-03-24 |
| FR6910M (xx) | 1969-04-28 |
| CS177802B2 (xx) | 1977-08-31 |
| ES342072A1 (es) | 1968-07-16 |
| FR1572961A (xx) | 1969-07-04 |
| GB1194183A (en) | 1970-06-10 |
| DE1643216A1 (de) | 1971-07-29 |
| BE700096A (xx) | 1967-12-18 |
| AT291220B (de) | 1971-07-12 |
| CH509273A (de) | 1971-06-30 |
| DK126376B (da) | 1973-07-09 |
| JPS4933941B1 (xx) | 1974-09-11 |
| SE339468B (xx) | 1971-10-11 |
| FI48461B (xx) | 1974-07-01 |
| NL6708561A (xx) | 1967-12-22 |
| JPS4927859B1 (xx) | 1974-07-22 |
| CA939385A (en) | 1974-01-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2559733C (en) | Inhibitors of histone deacetylase | |
| US4128658A (en) | Aminoalkyl furan derivatives | |
| NO170883B (no) | Fremgangsmaate for fremstilling av 2-amino-5-hydroksy-4-metylpyrimidin-derivater | |
| EA001534B1 (ru) | Производные циклической аминокислоты или их фармацевтически приемлемые соли, фармацевтическая композиция и способ лечения депрессии, состояний паники, страха и болевых ощущений | |
| DK158351B (da) | Analogifremgangsmaade til fremstilling af substituerede 4-fenylalkylimidazolderivater eller farmaceutisk acceptable syreadditionssalte deraf | |
| JP3101677B2 (ja) | ジフェニルピペラジン誘導体及びこれを含有する循環器用薬 | |
| HU181960B (en) | Process for producing substituted imidazolylmethylthio-compounds | |
| JPH06501707A (ja) | アミノスルホニル尿素ａｃａｔ阻害剤 | |
| EA001217B1 (ru) | СЕЛЕКТИВНЫЕ β-АДРЕНЕРГИЧЕСКИЕ АГОНИСТЫ | |
| SU453836A3 (ru) | Способ получения производных 3-бензилпиридина или их солей | |
| US3927097A (en) | 2-Thiopseudoureas | |
| Outcalt | On the reaction of 2‐chloroethylisothiocyanate with aromatic amines | |
| NO120145B (xx) | ||
| US2748122A (en) | 2-anilino-4, 6-dimethylpyrimidines | |
| US3073826A (en) | 3-pyrrolidylmethyl-4-quinazolones | |
| US4169855A (en) | N'-derivatives of n-(2-mercapto-ethyl)-2-nitro-1,1-ethenediamine | |
| PL128998B1 (en) | Process for preparing novel 2-amino-3-benzoylphenylacetamides and their derivatives | |
| KJ et al. | zsoThiocyanates VI. A Synthesis of Cheiroline (y-Methylsulphonylpropyl isoThiocyanate) | |
| NO761896L (xx) | ||
| US3728389A (en) | Biologically active amidines and their preparation | |
| US3342846A (en) | Asymmetrical diisothiocyanato benzenes | |
| JP2967231B2 (ja) | １，４―チアジン誘導体 | |
| WO2015184405A1 (en) | Aromatic compounds, compositions and uses thereof | |
| BRPI0613693A2 (pt) | aminas 8-alcóxi-4-metil-3,4-diidro-quinazolin-2-ila e seus usos como ligantes do receptor da 5-ht5a | |
| US3089876A (en) | 1-(beta-aminoethyl)-4-(beta-hydroxyethyl)-piperazine |